Skip to main content
. 2006 Feb 10;52(2):209.

Table 4.

Percentage of physicians reporting numbers of patients with AD seen in their practices in a typical month and percentage of patients with AD taking cholinesterase inhibitors

graphic file with name jCFP_v052_pg209_tab4.jpg

AD—Alzheimer disease.

*There was no significant difference across all regions in the number of patients with AD physicians reported in their practices (P = .999).

†There was a significant difference across all regions in percentage of patients with AD taking cholinesterase inhibitors (P = .009). All comparisons between regions with and without formulary coverage for cholinesterase inhibitors were significantly different (P < .035); comparisons between regions with similar formulary coverage were not significant (P > .35).